Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TRACON PHARMACEUTICALS, INC.

(TCON)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Slightly Higher in Premarket Thursday

07/22/2021 | 08:54am EDT


ę MT Newswires 2021
All news about TRACON PHARMACEUTICALS, INC.
09/13TRACON PHARMACEUTICALS : to Present at the Oppenheimer Fall Healthcare Life Sciences and M..
AQ
09/07TRACON PHARMACEUTICALS : to Present at the H.C. Wainwright 23rd Annual Global Investment C..
AQ
09/02TRACON PHARMACEUTICALS : to Present at the Wells Fargo Virtual Healthcare Conference
AQ
08/11TRACON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and R..
AQ
08/11TRACON : Q2 Earnings Snapshot
AQ
08/11TRACON PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Provides Corpor..
PU
08/11TRACON PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial St..
AQ
08/11Tracon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June..
CI
08/11TRACON Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corpo..
GL
08/09TRACON PHARMACEUTICALS : Announces Results of Second Independent Data Monitoring Committee..
AQ
More news
Analyst Recommendations on TRACON PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 0,22 M - -
Net income 2021 -26,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 -2,51x
Yield 2021 -
Capitalization 75,6 M 75,6 M -
Capi. / Sales 2021 339x
Capi. / Sales 2022 181x
Nbr of Employees 18
Free-Float 98,7%
Chart TRACON PHARMACEUTICALS, INC.
Duration : Period :
TRACON Pharmaceuticals, Inc. Technical Analysis Chart | TCON | US89237H2094 | MarketScreener
Technical analysis trends TRACON PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 3,89 $
Average target price 11,33 $
Spread / Average Target 191%
EPS Revisions
Managers and Directors
Charles P. Theuer President, Chief Executive Officer & Director
Scott B. Brown Chief Financial Officer
Bonne J. Adams Senior Vice President-Clinical Operations
James L. Freddo Chief Medical Officer
James R. Twiford Independent Director
Sector and Competitors
1st jan.Capi. (M$)
TRACON PHARMACEUTICALS, INC.-67.69%73
GILEAD SCIENCES, INC.21.80%88 970
BIONTECH SE315.86%81 878
WUXI APPTEC CO., LTD.35.75%69 413
REGENERON PHARMACEUTICALS32.66%66 632
VERTEX PHARMACEUTICALS-21.44%48 168